Role of rTMS and qEEG IN SCHIZOPHRENIA
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Schizophrenia
- Registration Number
- CTRI/2017/02/007948
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 45
Inclusion Criteria
1.Diagnosis of schizophrenia (F20.0-F20.9) according to Diagnostic Criteria for Research (DCR) of International classification of diseases-tenth edition (ICD-10; World Health Organization, 1992).
2.Patients should be on stable antipsychotic doses.
3.patients given written informed consent.
Exclusion Criteria
1. Current neurological or any co-morbid physical disorder
2. History of substance abuse (Except nicotine and caffeine in past one month)
3. History of epilepsy, significant head injury or any neurosurgical procedure
4. Subjects with cardiac pacemakers or other metal parts in the body
5. Subjects who have received ECT in past 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PSYRATS, PANSS and WHO DAS-2 ScoresTimepoint: Baseline, 2 WEEK & 4 WEEK
- Secondary Outcome Measures
Name Time Method Changes in wave frequencies(qEEG) viz., alpha, beta, theta, delta & gammaTimepoint: Base line, day-2 (after 1st cTBS) & DAY 14